ABSTRACT
Several reviews have focused on the nature of HIV infection and its spread in various geographical regions of China. In contrast, this review provides a comprehensive update on the prevalence of multiple HIV-1 subtypes, consequent emergence of recombinant and novel forms of HIV-1 in China, and the implications this may have on HIV diversity and the development of effective vaccines. In addition it also examines the dissemination of primary drug resistance in therapy naïve patients, as well as co-infections with two other important viruses-hepatitis B and C. The main purpose of this review is to provide a current snapshot of HIV-1 pathogenesis in China and possibly shed some light on the future of HIV evolution, and potential challenges for future vaccine and anti-retroviral therapeutics against HIV strains in this area.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
National Intelligence Council. The Next Wave of HIV/AIDS: Nigeria, Ethiopia, Russia, India, and China. 2002. http://www.fas.org/irp/nic/hiv-aids.html.
UNAIDS. UNAIDS China report. 2005. http://www.unaids.org.
Zeng Y, Fan J, Zhang Q, et al. Detection of antibody to LAV/HTLV-III in sera from hemophiliacs in China. AIDS Res 1986; 2 Suppl 1:S147–9.
Piyasirisilp S, McCutchan FE, Carr JK, et al. A recent outbreak of human immunodeficiency virus type 1 infection in southern China was initiated by two highly homogeneous, geographically separated strains, circulating recombinant form AE and a novel BC recombinant. J Virol 2000; 74:11286–95.
Sun X, Nan J, Guo Q . AIDS and HIV infection in China. AIDS 1994; 8 Suppl 2:S55–9.
Xia M, Kreiss JK, Holmes KK . Risk factors for HIV infection among drug users in Yunnan province, China: association with intravenous drug use and protective effect of boiling reusable needles and syringes. AIDS 1994; 8:1701–6.
Yang R, Xia X, Kusagawa S, et al. On-going generation of multiple forms of HIV-1 intersubtype recombinants in the Yunnan Province of China. AIDS 2002; 16:1401–7.
Avert ed. HIV and AIDS in China. 2005. http://www.avert.org/aidschina.htm
Zhang KL, Ma SJ . Epidemiology of HIV in China. BMJ 2002; 324:803–4.
China Ministry of Health and the UN Theme Group on HIV/AIDS in China. China Responds to AIDS: HIV/AIDS Situation and Needs Assessment Report. 1997.
Beyrer C, Razak MH, Lisam K, et al. Overland heroin trafficking routes and HIV-1 spread in south and south-east Asia. AIDS 2000; 14:75–83.
Zheng X, Tian C, Choi KH, et al. Injecting drug use and HIV infection in southwest China. AIDS 1994; 8:1141–7.
Kaufman J, Jing J . China and AIDS—the time to act is now. Science 2002; 296:2339–40.
Su B, Liu L, Wang F, et al. HIV-1 subtype B' dictates the AIDS epidemic among paid blood donors in the Henan and Hubei provinces of China. AIDS 2003; 17:2515–20.
Carr JK, Foley BT, Leitner T, et al. Reference Sequences Representing the Principal Genetic Diversity of HIV-1 in the Pandemic., in Human Retroviruses and AIDS 1998, K.C. Korber B, Foley B, Hahn B, McCutchan F, Mellors JW, and Sodroski J., Editor. 1998, Theoretical Biology and Biophysics Group: Los Alamos, NM. p. III-10–19.
McCutchan FE, Hegerich PA, Brennan TP, et al. Genetic variants of HIV-1 in Thailand. AIDS Res Hum Retroviruses 1992; 8:1887–95.
Weniger BG, Takebe Y, Ou CY, Yamazaki S . The molecular epidemiology of HIV in Asia. AIDS 1994; 8 Suppl 2:S13–28.
Tovanabutra S, Beyrer C, Sakkhachornphop S, et al. The changing molecular epidemiology of HIV type 1 among northern Thai drug users, 1999 to 2002. AIDS Res Hum Retroviruses 2004; 20:465–75.
Yang R, Kusagawa S, Zhang C, et al. Identification and characterization of a new class of human immunodeficiency virus type 1 recombinants comprised of two circulating recombinant forms, CRF07_BC and CRF08_BC, in China. J Virol 2003; 77:685–95.
Graf M, Shao Y, Zhao Q, et al. Cloning and characterization of a virtually full-length HIV type 1 genome from a subtype B'-Thai strain representing the most prevalent B-clade isolate in China. AIDS Res Hum Retroviruses 1998; 14:285–8.
Luo CC, Tian C, Hu DJ, et al. HIV-1 subtype C in China. Lancet 1995; 345:1051–2.
Su L, Graf M, Zhang Y, et al. Characterization of a virtually full-length human immunodeficiency virus type 1 genome of a prevalent intersubtype (C/B') recombinant strain in China. J Virol 2000; 74:11367–76.
UNAIDS/WHO. AIDS epidemic update, December 2004. 2004. http://www.unaids.org.
Lee WM . Hepatitis B virus infection. N Engl J Med 1997; 337:1733–45.
Thio CL, Seaberg EC, Skolasky R Jr, et al. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet 2002; 360:1921–6.
Levine OS, Vlahov D, Brookmeyer R, Cohn S, Nelson KE . Differences in the incidence of hepatitis B and human immunodeficiency virus infections among injecting drug users. J Infect Dis 1996; 173:579–83.
Martin-Carbonero L, Soriano V, Valencia E, et al. Increasing impact of chronic viral hepatitis on hospital admissions and mortality among HIV-infected patients. AIDS Res Hum Retroviruses 2001; 17:1467–71.
Shepard CW, Finelli L, Alter MJ . Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 2005; 5:558–67.
Zhang L, Chen Z, Cao Y, et al. Molecular characterization of human immunodeficiency virus type 1 and hepatitis C virus in paid blood donors and injection drug users in china. J Virol 2004; 78:13591–9.
Ruan YH, Hong KX, Liu SZ, et al. Community-based survey of HCV and HIV coinfection in injection drug abusers in Sichuan Province of China. World J Gastroenterol 2004; 10:1589–93.
Zhang C, Yang X, Xia X, et al. High prevalence of HIV-1 and hepatitis C virus coinfection among injection drug users in the southeastern region of Yunnan, China. J Acquir Immune Defic Syndr 2002; 29:191–6.
Zhang M, Sun XD, Mark SD, et al. Hepatitis C virus infection, Linxian, China. Emerg Infect Dis 2005; 11:17–21.
Boden D, Hurley A, Zhang L, et al. HIV-1 drug resistance in newly infected individuals. JAMA 1999; 282:1135–41.
Grant RM, Hecht FM, Warmerdam M, et al. Time trends in primary HIV-1 drug resistance among recently infected persons. JAMA 2002; 288:181–8.
Little SJ, Holte S, Routy JP, et al. Antiretroviral-drug resistance among patients recently infected with HIV. N Engl J Med 2002; 347:385–94.
Erice A, Mayers DL, Strike DG, et al. Brief report: primary infection with zidovudine-resistant human immunodeficiency virus type 1. N Engl J Med 1993; 328:1163–5.
Masquelier B, Lemoigne E, Pellegrin I, et al. Primary infection with zidovudine-resistant HIV. N Engl J Med 1993; 329:1123–4.
Veenstra J, Schuurman R, Cornelissen M, et al. Transmission of zidovudine-resistant human immunodeficiency virus type 1 variants following deliberate injection of blood from a patient with AIDS: characteristics and natural history of the virus. Clin Infect Dis 1995; 21:556–60.
Wong JK, Hezareh M, Gunthard HF, et al. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 1997; 278:1291–5.
Finzi D, Hermankova M, Pierson T, et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 1997; 278:1295–300.
Gianotti N, Boeri E, Maillard M, et al. In vivo dynamics of the 103N mutation following the withdrawal of non-nucleoside reverse transcriptase inhibitors in HIV-infected patients: preliminary results. New Microbiol 2004; 27:111–7.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
SAKSENA, N., WANG, B., STEAIN, M. et al. Snapshot of HIV pathogenesis in China. Cell Res 15, 953–961 (2005). https://doi.org/10.1038/sj.cr.7290373
Issue date:
DOI: https://doi.org/10.1038/sj.cr.7290373
